VNS terminating refractory nonconvulsive SE secondary to anti-NMDA encephalitis: A case report

Epilepsy and Behavior Case Reports

Volumn 3, Issue , 2015, Pages 39-42

  Alsaadi, Taoufik ^a   Shakra, Mustafa ^a   Turkawi, Lamya ^a   Hamid, Jassin ^a  

^a SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

Author keywords

Anti NMDA encephalitis; Refractory SE; VNS

Indexed keywords

ACICLOVIR; CEFTRIAXONE; CLONAZEPAM; ETIRACETAM; GLUCOSE; IMMUNOGLOBULIN; KETAMINE; MAGNESIUM SULFATE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; STEROID; TOPIRAMATE; VALPROIC ACID; VANCOMYCIN;

ADULT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODY BLOOD LEVEL; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG MONITORING; DRUG PULSE THERAPY; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAM; ENCEPHALITIS; EPILEPTIC STATE; FATTY ACID DESATURATION; FEVER; HEADACHE; HUMAN; IMPLANTED VAGUS NERVE STIMULATOR; LEUKOCYTE COUNT; LOADING DRUG DOSE; LUMBAR PUNCTURE; MALE; MIDDLE AGED; NEUROIMAGING; NONCONVULSIVE STATUS EPILEPTICUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TIC; TONIC CLONIC SEIZURE; TREATMENT DURATION; VAGUS NERVE STIMULATION;

EID: 84949644243     PISSN: 22133232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ebcr.2015.02.003     Document Type: Article

References (26)

1. Dalmau J., Gleichman A.J., Hughes E.G., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
2. Dalmau J., Tuzun E., Wu H., et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61:25-36.
3. Florance N.R., Davis R.L., Lam C., et al. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66:11-18.
4. Irani S.R., Bera K., Waters P., et al. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010, 133:1655-1667.
5. Johnson N., Henry C., Fessler A.J., et al. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010, 75:1480-1482.
6. Kirpatrick M.P., Clarke C.D., Sonmezturk H.H., et al. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 2011, 20:392-394.
7. Titulaer M.J., McCracken L., Gabilondo I., et al. Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-d-Aspartate (NMDA) receptor encephalitis: a cohort study. Lancet Neurol 2013, 12(2):157-165.
8. Ben-Menachem E., French J.A. VNS therapy versus the latest antiepileptic drug. Epileptic Disord 2005, 7(Suppl. 1):S22-S26.
9. Winston K.R., Levisohn P., Miller B.R., Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg 2001, 34:190-192.
10. Patwardhan R.V., Dellabadia J., Rashidi M., Grier L., Nanda A. Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report. Surg Neurol 2005, 64:170-173.
11. Carreño M., García-Álvarez D., Maestro I., et al. Malignant autosomal dominant frontal lobe epilepsy with repeated episodes of status epilepticus: successful treatment with vagal nerve stimulation. Epileptic Disord 2010, 12:155-158.
12. Viaccoz A, Desestret V, Ducray F, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 2014, 82:556-563.
13. Sansing L.H., Tüzün E., Ko M.W., Baccon J., Lynch D.R., Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007, 3:291-296.
14. Vitaliani R., Mason W., Ances B., Zwerdling T., Jiang Z., Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005, 58:594-604.
15. Drislane F.W., Blum A.S., Lopez M.R., et al. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009, 50:1566-1571.
16. Schmitt S.E., Pargeon K., Frechette E.S., Hirsch L.J., Dalmau J., Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012, 79:1094-1100.
17. Dalmau J., Lancaster E., Martinez-Hernandez M., et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10:63-71.
18. Sierra-Marcosa A., Maestrob I., Rodri'guez-Osorioc X., et al. Successful outcome of episodes of status epilepticus after vagus nerve stimulation: a multicenter study. Eur J Neurol 2012, 19:1219-1223.
19. DeGiorgio F.M., Schachter S.C., Handforth A., et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000, 41(9):1195-1200.
20. Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia 1992, 33:1005-1012.
21. Vonck K., Boon P., Van Laere, et al. Acute single photon emission computed tomographic study of vagus nerve stimulation in refractory epilepsy. Epilepsia 2000, 41:601-609.
22. Henry T.R., Bakay R.A., Pennell P.B., Epstein C.M., Votaw J.R. Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy. II. Prolonged effects at high and low levels of stimulation. Epilepsia 2004, 45:1064-1070.
23. Sucholeiki R., Alsaadi T., Morris G.L., Biswal B., Ulmer J., Mueller W. fMRI in patients with vagus nerve stimulation. Seizure 2002, 11(3):157-162.
24. De Herdt V., Bogaert S., Bracke K.R., et al. Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol 2009, 214:104-108.
25. Vezzani A., Balosso S., Aronica E., Ravizza T. Basic mechanisms of status epilepticus due to infection and inflammation. Epilepsia 2009, 50(Suppl. 12):56-57.
26. Koerner C., Danober L., Boehrer A., Marescaux C., Vergnes M. Thalamic NMDA transmission in a genetic model of absence epilepsy in rats. Epilepsy Res 1996, 25:11-19.